Form 8-K - Current report:
SEC Accession No. 0001558370-25-004490
Filing Date
2025-04-04
Accepted
2025-04-04 17:01:39
Documents
13
Period of Report
2025-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K mgtx-20250331x8k.htm   iXBRL 8-K 37457
  Complete submission text file 0001558370-25-004490.txt   157787

Data Files

Seq Description Document Type Size
2 EX-101.SCH mgtx-20250331.xsd EX-101.SCH 3406
3 EX-101.LAB mgtx-20250331_lab.xml EX-101.LAB 15925
4 EX-101.PRE mgtx-20250331_pre.xml EX-101.PRE 10050
15 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20250331x8k_htm.xml XML 4863
Mailing Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 646-860-7985
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

EIN.: 981448305 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38520 | Film No.: 25815651
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)